Nitazoxanide

Nitazoxanide, NITAZOXANIDE, 55981-09-4, Alinia, Nitazoxanida, Benzamide, 2-(acetyloxy)-N-(5-nitro-2-thiazolyl)-, Nitazoxanidum, 2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl acetate, 2-(Acetolyloxy)-N-(5-nitro-2-thiazolyl)benzamide, DTXSID5033757, NSC697855, NSC-697855, NSC-760057, PH 5776, PH-5776, SOA12P041N, Salicylamide, N-(5-nitro-2-thiazolyl)-, acetate (ester), DTXCID3013757, 2-((5-nitro-1,3-thiazol-2-yl)carbamoyl)phenyl acetate, RefChem:55715, P01AX11, Salicylamide, N-(5-nitro-2-thiazolyl)-, Acetate(Ester), 2-((5-nitrothiazol-2-yl)carbamoyl)phenyl acetate, Nitazoxamide, Nitazoxanid, Daxon, Nitazoxanidum [INN-Latin], Nitazoxanida [INN-Spanish], 2-(Acetyloxy)-N-(5-nitro-2-thiazolyl)benzamide, [2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl] acetate, C12H9N3O5S, MFCD00416599, NSC 697855, NTZ, 2-Acetyloxy-N-[(5-nitro-2-thiazolyl)]benzamide, N-(5-Nitrothiazol-2-yl)salicylamide acetate ester, [2-[(5-nitrothiazol-2-yl)carbamoyl]phenyl] acetate, MMV688991, o-(N-(5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate, NCGC00090774-01, Colufase, Cryptaz, Heliton, Phavic-1, O-[N-(5-nitrothiazol-2-yl)carbamoyl]phenyl acetate, SMR000466367, Alinia (TN), CAS-55981-09-4, S1627, 2-[(5-Nitrothiazol-2-yl)carbamoyl]phenyl Acetate, EINECS 259-931-8, Nitazoxanide (USAN/INN), (2-((5-Nitro-2-thiazolyl)carbamoyl)phenyl)acetat, BRN 1225475, UNII-SOA12P041N, N-(5-Nitro-2-thiazolyl)salicylamide acetate (ester), Nitrazoxanide, Pacovanton, Dexidex, Kidonax, Nitazox, Paramix, Nitax, Toza, Nitazoxanide [USAN:INN:BAN], YQNQNVDNTFHQSW-UHFFFAOYSA-N, Alinia(TM), CPD000466367, Nitazoxanide (Standard), NITAZOXANIDE [MI], NITAZOXANIDE [INN], NCIMech_000843, NITAZOXANIDE [USAN], CHEMBL1401, NITAZOXANIDE [VANDF], Oprea1_263587, SCHEMBL40981, NITAZOXANIDE [MART.], MLS000759492, MLS001424074, MLS006010127, NITAZOXANIDE [USP-RS], NITAZOXANIDE [WHO-DD], Nitazoxanide (Alinia, Annita), orb1308235, Nitazoxanide (Alinia, Annita)?, SCHEMBL29373905, CHEBI:94807, HY-B0217R, Nitazoxanide - Bio-X trade mark, NITAZOXANIDE [GREEN BOOK], Nitazoxanide, >=98% (HPLC), NTZ, NSC 697855, GLXC-05393, HMS2051L04, HMS3393L04, HMS3655M11, HMS3715F10, HMS5079I22, NITAZOXANIDE [ORANGE BOOK], Pharmakon1600-01503843, HY-B0217, Tox21_111018, Tox21_201226, BDBM50075050, CCG-35851, EBC-06082, MSK156811, NSC760057, STK395664, AKOS015915393, Tox21_111018_1, AC-1302, DB00507, FN26229, KS-1160, NC00246, NCGC00090774-02, NCGC00090774-03, NCGC00090774-04, NCGC00090774-05, NCGC00258778-01, BN164151, NCI60_034935, SY108901, N1031, Nitrazoxanide 100 microg/mL in Acetonitrile, NS00033434, ST51059722, SW197626-2, D02486, EN300-220095, AB00639988-07, AB00639988-09, AB00639988_10, AB00639988_11, 2-(acetyloxy)-N-(5-nitro-2-thiazolyl)-benzamide, F076695, SR-01000759418, Q2943789, SR-01000759418-9, BRD-K96471533-001-07-4, BRD-K96471533-001-08-2, BRD-K96471533-001-09-0, BRD-K96471533-001-10-8, NTZ, 2-(Acetyloxy)-N-(5-nitro-2-thiazolyl)benzamide, Salicylamide, N-(5-nitro-2-thiazolyl)- acetate (ester), Z1514087129, 2-[N-(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl acetate, Nitazoxanide, United States Pharmacopeia (USP) Reference Standard, acetic acid [2-[[(5-nitro-2-thiazolyl)amino]-oxomethyl]phenyl] ester, Zox